Fennec Pharmaceuticals Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| ROSALIND ADVISORS, INC. | 02/12/2026 | 2.61 M | $20.12 M | 25.84% | 9.37% |
| AIGH CAPITAL MANAGEMENT LLC | 02/02/2026 | 1.58 M | $12.18 M | 132.06% | 5.67% |
| BLACKROCK, INC. | 02/12/2026 | 1.23 M | $9.50 B | 1.85% | 4.43% |
| VANGUARD GROUP INC | 01/29/2026 | 1.07 M | $8.22 M | 11.71% | 3.83% |
| AWM INVESTMENT COMPANY, INC. | 02/13/2026 | 711.87 K | $5.48 M | 100.00% | 2.55% |
| STATE STREET CORP | 02/13/2026 | 352.78 K | $2.72 M | 3.39% | 1.26% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/09/2026 | 297.10 K | $2.29 M | -1.22% | 1.07% |
| MORGAN STANLEY | 02/13/2026 | 242.48 K | $1.87 M | 4.33% | 0.87% |
| CITADEL ADVISORS LLC | 02/17/2026 | 199.75 K | $1.54 M | 85.82% | 0.72% |
| GENDELL JEFFREY L | 02/13/2026 | 139.56 K | $1.07 M | 0.00% | 0.50% |
| MARSHALL WACE, LLP | 02/13/2026 | 127.69 K | $983.24 K | 100.00% | 0.46% |
| POTOMAC CAPITAL MANAGEMENT, INC. | 02/11/2026 | 95.10 K | $732.27 M | 100.00% | 0.34% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/13/2026 | 57.25 K | $440.82 K | 0.00% | 0.21% |
| HARTFORD FINANCIAL MANAGEMENT INC. | 01/21/2026 | 50.65 K | $389.98 K | 0.00% | 0.18% |
| STONEPINE CAPITAL MANAGEMENT, LLC | 02/13/2026 | 50.00 K | $385.00 K | 100.00% | 0.18% |
| BANK OF NEW YORK MELLON CORP | 02/10/2026 | 49.22 K | $378.99 K | -5.85% | 0.18% |
| HILLSDALE INVESTMENT MANAGEMENT INC. | 02/10/2026 | 44.00 K | $338.80 K | 100.00% | 0.16% |
| GOLDMAN SACHS GROUP INC | 02/10/2026 | 43.59 K | $335.64 K | 64.55% | 0.16% |
| BARCLAYS PLC | 02/13/2026 | 36.60 K | $281.80 K | 10.77% | 0.13% |
| RHUMBLINE ADVISERS | 02/13/2026 | 29.04 K | $223.59 K | -13.38% | 0.10% |
| 1492 CAPITAL MANAGEMENT LLC | 02/10/2026 | 28.09 K | $216.31 K | 100.00% | 0.10% |
| ACADIAN ASSET MANAGEMENT LLC | 02/10/2026 | 27.06 K | $207.00 K | 152.70% | 0.10% |
| XTX TOPCO LTD | 02/17/2026 | 26.79 K | $206.25 M | 26.07% | 0.10% |
| WELLS FARGO & COMPANY/MN | 02/13/2026 | 26.16 K | $201.42 K | 53.74% | 0.09% |
| NUVEEN, LLC | 02/12/2026 | 26.01 K | $200.25 M | 0.00% | 0.09% |
| JONES FINANCIAL COMPANIES LLLP | 02/17/2026 | 24.95 K | $192.13 K | 165.45% | 0.09% |
| JANE STREET GROUP, LLC | 02/12/2026 | 24.04 K | $185.14 M | -66.90% | 0.09% |
| RENAISSANCE TECHNOLOGIES LLC | 02/12/2026 | 20.00 K | $154.00 K | 88.68% | 0.07% |
| DEUTSCHE BANK AG\ | 02/11/2026 | 17.37 K | $133.71 K | 100.00% | 0.06% |
| AQR CAPITAL MANAGEMENT LLC | 02/17/2026 | 15.14 K | $116.57 K | 0.85% | 0.05% |
| HIGHTOWER ADVISORS, LLC | 02/06/2026 | 15.00 K | $115.50 K | 0.00% | 0.05% |
| SQUAREPOINT OPS LLC | 02/13/2026 | 13.11 K | $100.94 K | 100.00% | 0.05% |
| METLIFE INVESTMENT MANAGEMENT, LLC | 02/12/2026 | 13.02 K | $100.25 K | 35.71% | 0.05% |
| TWO SIGMA ADVISERS, LP | 02/17/2026 | 13.00 K | $100.10 K | 100.00% | 0.05% |
| INTECH INVESTMENT MANAGEMENT LLC | 02/10/2026 | 10.45 K | $80.48 K | -8.19% | 0.04% |
| JPMORGAN CHASE & CO | 02/11/2026 | 9.77 K | $75.24 K | -0.56% | 0.04% |
| NEW YORK STATE COMMON RETIREMENT FUND | 02/12/2026 | 9.75 K | $75.10 K | 0.00% | 0.04% |
| LEGAL & GENERAL GROUP PLC | 02/09/2026 | 8.13 K | $62.78 K | 0.00% | 0.03% |
| POLICE & FIREMEN'S RETIREMENT SYSTEM OF NEW JERSEY | 02/13/2026 | 6.25 K | $48.13 K | 0.00% | 0.02% |
| STRS OHIO | 02/02/2026 | 5.20 K | $40.04 K | 0.00% | 0.02% |
| BNP PARIBAS ARBITRAGE, SNC | 02/10/2026 | 5.05 K | $38.89 K | 12.05% | 0.02% |
| UBS GROUP AG | 01/29/2026 | 5.00 K | $38.46 M | -63.57% | 0.02% |
| FEDERATED HERMES, INC. | 02/12/2026 | 2.92 K | $22.45 K | 0.00% | 0.01% |
| ROYAL BANK OF CANADA | 02/17/2026 | 2.47 K | $19.00 K | 122.05% | 0.01% |
| STATE OF ALASKA, DEPARTMENT OF REVENUE | 01/23/2026 | 1.57 K | $12.00 K | 100.00% | 0.01% |
| CIBC PRIVATE WEALTH GROUP, LLC | 02/12/2026 | 1.57 K | $12.05 K | 0.00% | 0.01% |
| AMERITAS INVESTMENT PARTNERS, INC. | 02/11/2026 | 1.50 K | $11.54 K | 0.00% | 0.01% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 02/17/2026 | 1.38 K | $10.66 M | -14.78% | 0.01% |
| STERLING CAPITAL MANAGEMENT LLC | 02/13/2026 | 1.03 K | $7.93 K | -14.02% | 0.00% |
| CWM, LLC | 01/26/2026 | 750 | $6.00 K | -7.52% | 0.00% |
Fennec Pharmaceuticals Inc institutional Ownership - FAQ's
During the previous two years, 87 institutional investors and hedge funds held shares of Fennec Pharmaceuticals Inc. The most heavily invested institutionals were:
Rosalind Advisors, Inc.: 2.61 M
AIGH Capital Management LLC: 1.58 M
BlackRock, Inc.: 1.23 M
VANGUARD GROUP INC: 1.07 M
AWM Investment Company, Inc.: 711,869
STATE STREET CORP: 352,775
26.00% of Fennec Pharmaceuticals Inc stock is owned by institutional investors.
Institutional investors have bought a total of 16.14 M shares in the last 24 months. This purchase volume represents approximately $146.58 M in transactions.